**Core Concept**
The cytochrome P450 (CYP) enzyme system is a family of enzymes responsible for the metabolism of a wide range of drugs, including many prescribed medications. Inhibitors of these enzymes can lead to increased levels of their substrates, potentially causing adverse effects or drug interactions.

**Why the Correct Answer is Right**
CYP enzymes are involved in the oxidative metabolism of many drugs. Inhibitors of these enzymes, such as **ketoconazole**, **itraconazole**, and **erythromycin**, can block the action of CYP enzymes, leading to decreased metabolism and increased levels of their substrates. This can result in increased side effects or interactions with other medications. **Ketoconazole**, in particular, is a potent inhibitor of CYP3A4, a key enzyme involved in the metabolism of many medications.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not specified, so we cannot evaluate its accuracy. However, we can discuss the characteristics of a CYP inhibitor.
**Option B:** While some macrolide antibiotics, such as erythromycin, are CYP inhibitors, this option is not specific or accurate.
**Option C:** This option is not specified, so we cannot evaluate its accuracy.

**Clinical Pearl / High-Yield Fact**
When prescribing medications, it is essential to consider potential drug interactions and the effects of CYP inhibitors on their metabolism. This includes monitoring for increased side effects or toxicity when co-administering CYP inhibitors with other medications.

**Correct Answer:** C. Ketoconazole